MedPath

NEW YORK MEDICAL COLLEGE

NEW YORK MEDICAL COLLEGE logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1860-01-01
Employees
501
Market Cap
-
Website
http://www.nymc.edu

CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma

Phase 1
Not yet recruiting
Conditions
Classical Hodgkin Lymphoma
Interventions
Biological: CD30 CAR T-cell
First Posted Date
2024-09-27
Last Posted Date
2024-10-18
Lead Sponsor
New York Medical College
Target Recruit Count
21
Registration Number
NCT06617286
Locations
🇺🇸

New York Medical College, Valhalla, New York, United States

E-B-FAHF-2, Multi OIT and Xolair for Food Allergy

Phase 2
Completed
Conditions
Food Allergy
First Posted Date
2023-10-27
Last Posted Date
2024-03-25
Lead Sponsor
New York Medical College
Target Recruit Count
33
Registration Number
NCT06103656

Defibrotide Dose-escalation for SOS Post-HSCT

Phase 2
Recruiting
Conditions
Sinusoidal Obstruction Syndrome
Veno-occlusive Disease
Interventions
First Posted Date
2023-08-14
Last Posted Date
2024-03-26
Lead Sponsor
New York Medical College
Target Recruit Count
20
Registration Number
NCT05987124
Locations
🇺🇸

New York Medical College, Valhalla, New York, United States

Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia

Not Applicable
Recruiting
Conditions
Hypocapnia
Postural Orthostatic Tachycardia Syndrome
Hyperventilation
Interventions
Diagnostic Test: Chemoreflex Testing
Diagnostic Test: Baroreflex testing
Diagnostic Test: Orthostatic stress testing
First Posted Date
2023-06-28
Last Posted Date
2023-06-28
Lead Sponsor
New York Medical College
Target Recruit Count
30
Registration Number
NCT05923840
Locations
🇺🇸

NewYork Medical College, Hawthorne, New York, United States

Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life

Not Applicable
Completed
Conditions
Low Back Pain
Interventions
Other: T'ai Chi and Qigong Rehabilitation
Other: Usual care
First Posted Date
2023-04-06
Last Posted Date
2024-03-25
Lead Sponsor
New York Medical College
Target Recruit Count
350
Registration Number
NCT05801588
Locations
🇺🇸

New York Medical College, Valhalla, New York, United States

CMV CTLs in Neonates With CMV Infection

Phase 2
Recruiting
Conditions
Congenital Cytomegaloviral (CMV) Disease
Interventions
Biological: CMV Cytotoxic T-Lymphocytes
Drug: Anti-viral Therapy
First Posted Date
2022-10-03
Last Posted Date
2025-05-06
Lead Sponsor
New York Medical College
Target Recruit Count
23
Registration Number
NCT05564598
Locations
🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

🇺🇸

Washington University, Saint Louis, Missouri, United States

🇺🇸

New York Medical College, Vallhala, New York, United States

and more 1 locations

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

Phase 2
Recruiting
Conditions
Non-hodgkin Lymphoma
Hodgkin Lymphoma
Interventions
Drug: DOC Group B
Drug: Bv-NVD-R, Cycle 1-2
Drug: DOC Group C
Drug: Bv-AVD-R
Drug: Bv-NVD-R, Cycle 1-4 RER
Drug: Pv-COMRAD 1 and 2 Group B
Drug: Bv-NVD-R, Cycle 1-4 SER
Drug: MAD CPR 1 and 2
Drug: Pv-R-CYM 1 and 2 Group B
Drug: Bv-NAVD-R, Cycle 1-2
Drug: Pv-R CYVE 1 and 2
Drug: Pv-R CYVE-MTX 1 and 2
Drug: Pv-Cytarabine/etoposide
Radiation: Involved Site Radiation Therapy
First Posted Date
2022-02-23
Last Posted Date
2023-10-26
Lead Sponsor
New York Medical College
Target Recruit Count
80
Registration Number
NCT05253495
Locations
🇺🇸

University of Alabama, Birmingham, Alabama, United States

🇺🇸

New York Medical College, Valhalla, New York, United States

🇺🇸

University of Flordia, Gainesville, Florida, United States

Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes

Conditions
Trauma Abdomen
Intestinal Perforation
Intestinal Obstruction
First Posted Date
2022-01-26
Last Posted Date
2022-01-26
Lead Sponsor
New York Medical College
Target Recruit Count
108
Registration Number
NCT05208489
Locations
🇺🇸

New York Medical College, Valhalla, New York, United States

To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections

Terminated
Conditions
Necrotizing Soft Tissue Infection
First Posted Date
2021-09-02
Last Posted Date
2021-09-02
Lead Sponsor
New York Medical College
Target Recruit Count
13
Registration Number
NCT05032625
Locations
🇺🇸

Westchester Medical center, Valhalla, New York, United States

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma

Phase 1
Recruiting
Conditions
T-cell Acute Lymphoblastic Leukemia
T-Cell Acute Lymphoblastic Lymphoma
Interventions
First Posted Date
2021-07-22
Last Posted Date
2025-03-13
Lead Sponsor
New York Medical College
Target Recruit Count
30
Registration Number
NCT04972942
Locations
🇺🇸

Phoenix Children's Hospital, Phoeniz, Arizona, United States

🇺🇸

Loma Linda University Children's Hospital, Loma Linda, California, United States

🇺🇸

University of California, San Francisco, California, United States

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath